RESEARCH SITE s.r.o
- Address
- lock Available on a paid plan
RESEARCH SITE s.r.o - Hepatobiliary Disease Research
RESEARCH SITE s.r.o is a clinical research center with specialized expertise in hepatobiliary disorders, particularly focusing on chronic liver diseases. The center demonstrates significant experience in conducting Phase 3 clinical trials evaluating novel therapeutic approaches for patients with complex cholestatic liver conditions.
- Primary biliary cholangitis (PBC) and associated complications
- Cholestatic pruritus management and symptom control
- Long-term safety and tolerability studies in hepatic disorders
The center's research portfolio emphasizes advanced therapeutic interventions for cholestasis and its debilitating symptoms, with particular attention to evaluating the long-term safety profiles of innovative treatments. Their work in primary biliary cholangitis contributes to improving quality of life for patients suffering from cholestatic pruritus, addressing a significant unmet medical need in this patient population.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Ipsen Bioscience Inc.2active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Ipsen Bioscience Inc.3trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in RESEARCH SITE s.r.o
lock Showing 1 of 9 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Elafibranor in Adult Patients with Primary Biliary Cholangitis: A Phase III Randomized, Double-Blind, Placebo-Controlled Study | Ipsen Bioscience Inc. | Phase III | Recruiting | Feb 2024 | — |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Elafibranor | 3 | Unknown | 2024-02-28 | 2024-10-15 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.